Neuro-Spinal Scaffold
-
Biologics
InVivo Therapeutics Announces Joint Research Collaboration with Q Therapeutics, Inc.
October 02, 2018 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a…
Read More » -
Neuro
InVivo to Initiate Cervical Spinal Cord Injury Study
March 23, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that Health Canada has approved the company’s Investigational Testing…
Read More » -
Spine
InVivo Therapeutics Reports Significant Improvement of First Patient Implanted with Neuro-Spinal Scaffold™
CAMBRIDGE, Mass., Oct 23, 2015 (BUSINESS WIRE) — InVivo Therapeutics Holdings Corp. (NVIV) today announced a 12-month post-implant update for the first…
Read More » -
Recon
InVivo Therapeutics Reports Update of First Two Spinal Cord Injury Patients Implanted with Neuro-Spinal Scaffold
CAMBRIDGE, Mass., May 14, 2015 (BUSINESS WIRE) — InVivo Therapeutics Holdings Corp. (NVIV) today announced a six-month post-implant update for the…
Read More »